Stay updated on Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T13:09:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T13:48:12.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.7.0, replacing the previous v3.6.6. This indicates a software version update for the study history interface.
    Difference
    0.1%
    Check dated 2026-09-20T19:45:54.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry labeled Revision: v3.6.6, indicating the latest update to the study record. The previous revision entry Revision: v3.6.5 was removed from the history.
    Difference
    0.1%
    Check dated 2026-08-30T16:05:26.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    New revision tag Revision: v3.6.5 has been added to the history table, replacing Revision: v3.6.4. This indicates the record has been updated to a newer revision.
    Difference
    0.1%
    Check dated 2026-08-08T23:29:54.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4. This reflects a minor update to the study history display.
    Difference
    0.1%
    Check dated 2026-07-25T16:48:54.000Z thumbnail image

Stay in the know with updates to Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page.